Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Abroad (travel likely)RecruitingPHASE1
Conditions
Mesothelioma · Neoplasms · Stomach Neoplasms · Pancreatic Neoplasms · Ovarian Neoplasms · Lung Neoplasms · Thymus Neoplasms · Colonic Neoplasms
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (National Cancer Institute Referral Office) · ncimo_referrals@mail.nih.gov · 888-624-1937
Study leads
Raffit Hassan, M.D.
Principal Investigator
National Cancer Institute (NCI)